nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethosuximide—Hirsutism—Capecitabine—esophageal cancer	0.00639	0.031	CcSEcCtD
Ethosuximide—Tongue disorder—Capecitabine—esophageal cancer	0.0051	0.0248	CcSEcCtD
Ethosuximide—Hiccups—Cisplatin—esophageal cancer	0.00503	0.0244	CcSEcCtD
Ethosuximide—Vaginal haemorrhage—Capecitabine—esophageal cancer	0.00501	0.0243	CcSEcCtD
Ethosuximide—Rash erythematous—Capecitabine—esophageal cancer	0.00485	0.0235	CcSEcCtD
Ethosuximide—Hiccups—Capecitabine—esophageal cancer	0.00371	0.018	CcSEcCtD
Ethosuximide—Irritability—Cisplatin—esophageal cancer	0.00349	0.0169	CcSEcCtD
Ethosuximide—Breast disorder—Cisplatin—esophageal cancer	0.0033	0.016	CcSEcCtD
Ethosuximide—Cramp muscle—Cisplatin—esophageal cancer	0.00329	0.016	CcSEcCtD
Ethosuximide—Mental disability—Capecitabine—esophageal cancer	0.00322	0.0156	CcSEcCtD
Ethosuximide—Sleep disorder—Capecitabine—esophageal cancer	0.00311	0.0151	CcSEcCtD
Ethosuximide—Abdominal discomfort—Cisplatin—esophageal cancer	0.00303	0.0147	CcSEcCtD
Ethosuximide—Pancytopenia—Cisplatin—esophageal cancer	0.003	0.0146	CcSEcCtD
Ethosuximide—Lethargy—Capecitabine—esophageal cancer	0.00275	0.0133	CcSEcCtD
Ethosuximide—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.00267	0.013	CcSEcCtD
Ethosuximide—Aplastic anaemia—Methotrexate—esophageal cancer	0.00259	0.0126	CcSEcCtD
Ethosuximide—Irritability—Capecitabine—esophageal cancer	0.00257	0.0125	CcSEcCtD
Ethosuximide—Ataxia—Capecitabine—esophageal cancer	0.00253	0.0123	CcSEcCtD
Ethosuximide—Urinary tract disorder—Cisplatin—esophageal cancer	0.0025	0.0121	CcSEcCtD
Ethosuximide—Connective tissue disorder—Cisplatin—esophageal cancer	0.00248	0.0121	CcSEcCtD
Ethosuximide—Urethral disorder—Cisplatin—esophageal cancer	0.00248	0.012	CcSEcCtD
Ethosuximide—Abdominal pain upper—Capecitabine—esophageal cancer	0.00246	0.0119	CcSEcCtD
Ethosuximide—Breast disorder—Capecitabine—esophageal cancer	0.00243	0.0118	CcSEcCtD
Ethosuximide—Eye disorder—Cisplatin—esophageal cancer	0.00236	0.0115	CcSEcCtD
Ethosuximide—Immune system disorder—Cisplatin—esophageal cancer	0.00228	0.0111	CcSEcCtD
Ethosuximide—Mediastinal disorder—Cisplatin—esophageal cancer	0.00228	0.0111	CcSEcCtD
Ethosuximide—Abdominal discomfort—Capecitabine—esophageal cancer	0.00223	0.0108	CcSEcCtD
Ethosuximide—Pancytopenia—Capecitabine—esophageal cancer	0.00221	0.0107	CcSEcCtD
Ethosuximide—Malnutrition—Cisplatin—esophageal cancer	0.0022	0.0107	CcSEcCtD
Ethosuximide—Muscle spasms—Cisplatin—esophageal cancer	0.00212	0.0103	CcSEcCtD
Ethosuximide—Weight decreased—Capecitabine—esophageal cancer	0.00211	0.0102	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.00206	0.00999	CcSEcCtD
Ethosuximide—Lethargy—Methotrexate—esophageal cancer	0.00205	0.00993	CcSEcCtD
Ethosuximide—Haematuria—Capecitabine—esophageal cancer	0.00198	0.0096	CcSEcCtD
Ethosuximide—Leukopenia—Cisplatin—esophageal cancer	0.00197	0.00956	CcSEcCtD
Ethosuximide—Agranulocytosis—Capecitabine—esophageal cancer	0.00194	0.0094	CcSEcCtD
Ethosuximide—Irritability—Methotrexate—esophageal cancer	0.00191	0.00929	CcSEcCtD
Ethosuximide—Ataxia—Methotrexate—esophageal cancer	0.00189	0.00915	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00186	0.00903	CcSEcCtD
Ethosuximide—Urinary tract disorder—Capecitabine—esophageal cancer	0.00184	0.00893	CcSEcCtD
Ethosuximide—Connective tissue disorder—Capecitabine—esophageal cancer	0.00183	0.00889	CcSEcCtD
Ethosuximide—Urethral disorder—Capecitabine—esophageal cancer	0.00183	0.00886	CcSEcCtD
Ethosuximide—Breast disorder—Methotrexate—esophageal cancer	0.00181	0.00879	CcSEcCtD
Ethosuximide—Erythema multiforme—Capecitabine—esophageal cancer	0.00176	0.00855	CcSEcCtD
Ethosuximide—Nervous system disorder—Cisplatin—esophageal cancer	0.00176	0.00855	CcSEcCtD
Ethosuximide—Skin disorder—Cisplatin—esophageal cancer	0.00174	0.00847	CcSEcCtD
Ethosuximide—Eye disorder—Capecitabine—esophageal cancer	0.00174	0.00845	CcSEcCtD
Ethosuximide—Eosinophilia—Methotrexate—esophageal cancer	0.00172	0.00833	CcSEcCtD
Ethosuximide—Anorexia—Cisplatin—esophageal cancer	0.00171	0.00831	CcSEcCtD
Ethosuximide—Immune system disorder—Capecitabine—esophageal cancer	0.00168	0.00817	CcSEcCtD
Ethosuximide—Mediastinal disorder—Capecitabine—esophageal cancer	0.00168	0.00815	CcSEcCtD
Ethosuximide—Abdominal discomfort—Methotrexate—esophageal cancer	0.00166	0.00806	CcSEcCtD
Ethosuximide—CYP3A5—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.00166	0.00209	CbGpPWpGaD
Ethosuximide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.00165	0.00208	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—ADH1B—esophageal cancer	0.00165	0.00208	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—ADH1B—esophageal cancer	0.00165	0.00208	CbGpPWpGaD
Ethosuximide—Pancytopenia—Methotrexate—esophageal cancer	0.00165	0.00799	CcSEcCtD
Ethosuximide—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.00164	0.00207	CbGpPWpGaD
Ethosuximide—Mental disorder—Capecitabine—esophageal cancer	0.00163	0.00792	CcSEcCtD
Ethosuximide—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.00163	0.00206	CbGpPWpGaD
Ethosuximide—Malnutrition—Capecitabine—esophageal cancer	0.00162	0.00787	CcSEcCtD
Ethosuximide—CYP3A7—Biological oxidations—ALDH2—esophageal cancer	0.00161	0.00202	CbGpPWpGaD
Ethosuximide—Decreased appetite—Cisplatin—esophageal cancer	0.00156	0.00758	CcSEcCtD
Ethosuximide—CYP2E1—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.00156	0.00197	CbGpPWpGaD
Ethosuximide—Muscle spasms—Capecitabine—esophageal cancer	0.00156	0.00757	CcSEcCtD
Ethosuximide—CYP3A5—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.00156	0.00196	CbGpPWpGaD
Ethosuximide—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00155	0.00752	CcSEcCtD
Ethosuximide—CYP3A4—Tryptophan metabolism—ALDH2—esophageal cancer	0.00155	0.00195	CbGpPWpGaD
Ethosuximide—Drowsiness—Methotrexate—esophageal cancer	0.00155	0.0075	CcSEcCtD
Ethosuximide—CYP2E1—Biological oxidations—CYP26A1—esophageal cancer	0.00154	0.00193	CbGpPWpGaD
Ethosuximide—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.00153	0.00743	CcSEcCtD
Ethosuximide—CYP3A5—Biological oxidations—CYP26A1—esophageal cancer	0.00153	0.00193	CbGpPWpGaD
Ethosuximide—CYP3A7—Biological oxidations—GSTT1—esophageal cancer	0.00153	0.00192	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—SLC52A3—esophageal cancer	0.00153	0.00192	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—BLVRB—esophageal cancer	0.00153	0.00192	CbGpPWpGaD
Ethosuximide—CYP2E1—Metapathway biotransformation—CYP26A1—esophageal cancer	0.00151	0.00191	CbGpPWpGaD
Ethosuximide—CYP3A5—Metapathway biotransformation—CYP26A1—esophageal cancer	0.00151	0.0019	CbGpPWpGaD
Ethosuximide—CYP3A7—Biological oxidations—CYP2A6—esophageal cancer	0.00151	0.0019	CbGpPWpGaD
Ethosuximide—Haematuria—Methotrexate—esophageal cancer	0.00147	0.00715	CcSEcCtD
Ethosuximide—Leukopenia—Capecitabine—esophageal cancer	0.00145	0.00705	CcSEcCtD
Ethosuximide—Agranulocytosis—Methotrexate—esophageal cancer	0.00144	0.007	CcSEcCtD
Ethosuximide—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.00144	0.00182	CbGpPWpGaD
Ethosuximide—CYP3A7—Biological oxidations—PTGS1—esophageal cancer	0.00143	0.0018	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—GSTO1—esophageal cancer	0.00143	0.0018	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—GSTO1—esophageal cancer	0.00142	0.00179	CbGpPWpGaD
Ethosuximide—CYP2E1—Metapathway biotransformation—GSTO1—esophageal cancer	0.00141	0.00177	CbGpPWpGaD
Ethosuximide—CYP3A5—Metapathway biotransformation—GSTO1—esophageal cancer	0.0014	0.00177	CbGpPWpGaD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00137	0.00666	CcSEcCtD
Ethosuximide—Urinary tract disorder—Methotrexate—esophageal cancer	0.00137	0.00665	CcSEcCtD
Ethosuximide—Urethral disorder—Methotrexate—esophageal cancer	0.00136	0.0066	CcSEcCtD
Ethosuximide—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.00134	0.00169	CbGpPWpGaD
Ethosuximide—Hypersensitivity—Cisplatin—esophageal cancer	0.00132	0.00642	CcSEcCtD
Ethosuximide—CACNA1G—Axon guidance—KDR—esophageal cancer	0.00132	0.00166	CbGpPWpGaD
Ethosuximide—Erythema multiforme—Methotrexate—esophageal cancer	0.00131	0.00636	CcSEcCtD
Ethosuximide—Nervous system disorder—Capecitabine—esophageal cancer	0.0013	0.0063	CcSEcCtD
Ethosuximide—CYP3A43—Metabolism—SLC10A2—esophageal cancer	0.0013	0.00164	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CA1—esophageal cancer	0.0013	0.00164	CbGpPWpGaD
Ethosuximide—Eye disorder—Methotrexate—esophageal cancer	0.0013	0.00629	CcSEcCtD
Ethosuximide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	0.00129	0.00163	CbGpPWpGaD
Ethosuximide—Asthenia—Cisplatin—esophageal cancer	0.00129	0.00625	CcSEcCtD
Ethosuximide—CACNA1G—Axon guidance—MET—esophageal cancer	0.00129	0.00162	CbGpPWpGaD
Ethosuximide—Skin disorder—Capecitabine—esophageal cancer	0.00129	0.00624	CcSEcCtD
Ethosuximide—Anorexia—Capecitabine—esophageal cancer	0.00126	0.00612	CcSEcCtD
Ethosuximide—Immune system disorder—Methotrexate—esophageal cancer	0.00125	0.00608	CcSEcCtD
Ethosuximide—Mediastinal disorder—Methotrexate—esophageal cancer	0.00125	0.00607	CcSEcCtD
Ethosuximide—CACNA1G—Developmental Biology—ABL1—esophageal cancer	0.00124	0.00156	CbGpPWpGaD
Ethosuximide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.00123	0.00155	CbGpPWpGaD
Ethosuximide—Diarrhoea—Cisplatin—esophageal cancer	0.00123	0.00596	CcSEcCtD
Ethosuximide—CYP3A7—Biological oxidations—CYP1B1—esophageal cancer	0.00122	0.00153	CbGpPWpGaD
Ethosuximide—Mental disorder—Methotrexate—esophageal cancer	0.00122	0.0059	CcSEcCtD
Ethosuximide—Malnutrition—Methotrexate—esophageal cancer	0.00121	0.00586	CcSEcCtD
Ethosuximide—CACNA1G—Developmental Biology—SMAD4—esophageal cancer	0.0012	0.00151	CbGpPWpGaD
Ethosuximide—CYP3A7—Metapathway biotransformation—CYP1B1—esophageal cancer	0.0012	0.00151	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CA2—esophageal cancer	0.00119	0.0015	CbGpPWpGaD
Ethosuximide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.00118	0.00148	CbGpPWpGaD
Ethosuximide—CYP3A4—Tryptophan metabolism—CYP1B1—esophageal cancer	0.00117	0.00148	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—ALDH2—esophageal cancer	0.00116	0.00147	CbGpPWpGaD
Ethosuximide—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.00116	0.00146	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—ALDH2—esophageal cancer	0.00116	0.00146	CbGpPWpGaD
Ethosuximide—Decreased appetite—Capecitabine—esophageal cancer	0.00115	0.00558	CcSEcCtD
Ethosuximide—CYP3A7—Biological oxidations—CYP19A1—esophageal cancer	0.00114	0.00144	CbGpPWpGaD
Ethosuximide—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00114	0.00555	CcSEcCtD
Ethosuximide—Vomiting—Cisplatin—esophageal cancer	0.00114	0.00554	CcSEcCtD
Ethosuximide—Fatigue—Capecitabine—esophageal cancer	0.00114	0.00554	CcSEcCtD
Ethosuximide—Rash—Cisplatin—esophageal cancer	0.00113	0.0055	CcSEcCtD
Ethosuximide—Dermatitis—Cisplatin—esophageal cancer	0.00113	0.00549	CcSEcCtD
Ethosuximide—CYP3A7—Metapathway biotransformation—CYP19A1—esophageal cancer	0.00113	0.00142	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—GSTT1—esophageal cancer	0.00111	0.00139	CbGpPWpGaD
Ethosuximide—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	0.0011	0.00139	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—GSTT1—esophageal cancer	0.0011	0.00139	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—ADH7—esophageal cancer	0.0011	0.00139	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PLCE1—esophageal cancer	0.0011	0.00139	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—CYP2A6—esophageal cancer	0.00109	0.00138	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—CYP2A6—esophageal cancer	0.00109	0.00137	CbGpPWpGaD
Ethosuximide—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00108	0.00525	CcSEcCtD
Ethosuximide—Leukopenia—Methotrexate—esophageal cancer	0.00108	0.00525	CcSEcCtD
Ethosuximide—Nausea—Cisplatin—esophageal cancer	0.00107	0.00518	CcSEcCtD
Ethosuximide—Urticaria—Capecitabine—esophageal cancer	0.00105	0.0051	CcSEcCtD
Ethosuximide—Abdominal pain—Capecitabine—esophageal cancer	0.00105	0.00508	CcSEcCtD
Ethosuximide—CYP2E1—Biological oxidations—PTGS1—esophageal cancer	0.00104	0.00131	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—PTGS1—esophageal cancer	0.00103	0.0013	CbGpPWpGaD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00102	0.00495	CcSEcCtD
Ethosuximide—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.00102	0.00128	CbGpPWpGaD
Ethosuximide—Hypersensitivity—Capecitabine—esophageal cancer	0.000976	0.00473	CcSEcCtD
Ethosuximide—CYP3A43—Metabolism—ADH1B—esophageal cancer	0.000968	0.00122	CbGpPWpGaD
Ethosuximide—Nervous system disorder—Methotrexate—esophageal cancer	0.000967	0.00469	CcSEcCtD
Ethosuximide—Skin disorder—Methotrexate—esophageal cancer	0.000957	0.00465	CcSEcCtD
Ethosuximide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000955	0.0012	CbGpPWpGaD
Ethosuximide—Asthenia—Capecitabine—esophageal cancer	0.00095	0.00461	CcSEcCtD
Ethosuximide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.00095	0.0012	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—ERBB2—esophageal cancer	0.000942	0.00119	CbGpPWpGaD
Ethosuximide—Anorexia—Methotrexate—esophageal cancer	0.00094	0.00456	CcSEcCtD
Ethosuximide—CACNA1G—Developmental Biology—KDR—esophageal cancer	0.000939	0.00118	CbGpPWpGaD
Ethosuximide—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000937	0.00118	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—TYMP—esophageal cancer	0.000925	0.00117	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—MET—esophageal cancer	0.000919	0.00116	CbGpPWpGaD
Ethosuximide—Diarrhoea—Capecitabine—esophageal cancer	0.000906	0.0044	CcSEcCtD
Ethosuximide—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000906	0.00114	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CYP26A1—esophageal cancer	0.0009	0.00113	CbGpPWpGaD
Ethosuximide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000893	0.00112	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—NOTCH1—esophageal cancer	0.000885	0.00111	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—CYP1B1—esophageal cancer	0.000882	0.00111	CbGpPWpGaD
Ethosuximide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000881	0.00111	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—CYP1B1—esophageal cancer	0.00088	0.00111	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—ALOX15—esophageal cancer	0.000877	0.0011	CbGpPWpGaD
Ethosuximide—Somnolence—Methotrexate—esophageal cancer	0.000876	0.00425	CcSEcCtD
Ethosuximide—Dizziness—Capecitabine—esophageal cancer	0.000876	0.00425	CcSEcCtD
Ethosuximide—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.000874	0.0011	CbGpPWpGaD
Ethosuximide—CYP2E1—Metapathway biotransformation—CYP1B1—esophageal cancer	0.00087	0.0011	CbGpPWpGaD
Ethosuximide—CYP3A5—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000868	0.00109	CbGpPWpGaD
Ethosuximide—Decreased appetite—Methotrexate—esophageal cancer	0.000857	0.00416	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000851	0.00413	CcSEcCtD
Ethosuximide—Fatigue—Methotrexate—esophageal cancer	0.00085	0.00412	CcSEcCtD
Ethosuximide—Vomiting—Capecitabine—esophageal cancer	0.000842	0.00408	CcSEcCtD
Ethosuximide—CYP3A43—Metabolism—TPI1—esophageal cancer	0.000837	0.00105	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—GSTO1—esophageal cancer	0.000837	0.00105	CbGpPWpGaD
Ethosuximide—Rash—Capecitabine—esophageal cancer	0.000835	0.00405	CcSEcCtD
Ethosuximide—Dermatitis—Capecitabine—esophageal cancer	0.000834	0.00405	CcSEcCtD
Ethosuximide—Headache—Capecitabine—esophageal cancer	0.000829	0.00402	CcSEcCtD
Ethosuximide—CYP2E1—Biological oxidations—CYP19A1—esophageal cancer	0.000829	0.00104	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—CYP19A1—esophageal cancer	0.000827	0.00104	CbGpPWpGaD
Ethosuximide—CYP2E1—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000818	0.00103	CbGpPWpGaD
Ethosuximide—CYP3A5—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000816	0.00103	CbGpPWpGaD
Ethosuximide—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000806	0.00391	CcSEcCtD
Ethosuximide—CACNA1G—Developmental Biology—CREBBP—esophageal cancer	0.000802	0.00101	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—ALDOB—esophageal cancer	0.000802	0.00101	CbGpPWpGaD
Ethosuximide—Nausea—Capecitabine—esophageal cancer	0.000786	0.00382	CcSEcCtD
Ethosuximide—Urticaria—Methotrexate—esophageal cancer	0.000783	0.0038	CcSEcCtD
Ethosuximide—Abdominal pain—Methotrexate—esophageal cancer	0.000779	0.00378	CcSEcCtD
Ethosuximide—CYP3A43—Metabolism—GAPDH—esophageal cancer	0.000772	0.000972	CbGpPWpGaD
Ethosuximide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.00077	0.00097	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000766	0.000965	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CRABP1—esophageal cancer	0.000765	0.000964	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—GNG7—esophageal cancer	0.000728	0.000917	CbGpPWpGaD
Ethosuximide—Hypersensitivity—Methotrexate—esophageal cancer	0.000726	0.00352	CcSEcCtD
Ethosuximide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000724	0.000912	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000712	0.000897	CbGpPWpGaD
Ethosuximide—Asthenia—Methotrexate—esophageal cancer	0.000707	0.00343	CcSEcCtD
Ethosuximide—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000702	0.000885	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—ALDH2—esophageal cancer	0.000682	0.000859	CbGpPWpGaD
Ethosuximide—Diarrhoea—Methotrexate—esophageal cancer	0.000674	0.00327	CcSEcCtD
Ethosuximide—CACNA1G—Developmental Biology—ERBB2—esophageal cancer	0.000672	0.000846	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.000662	0.000834	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000653	0.000823	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—EGFR—esophageal cancer	0.000653	0.000822	CbGpPWpGaD
Ethosuximide—Dizziness—Methotrexate—esophageal cancer	0.000652	0.00316	CcSEcCtD
Ethosuximide—CYP3A43—Metabolism—GSTT1—esophageal cancer	0.000649	0.000817	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CYP2A6—esophageal cancer	0.000641	0.000808	CbGpPWpGaD
Ethosuximide—Vomiting—Methotrexate—esophageal cancer	0.000627	0.00304	CcSEcCtD
Ethosuximide—Rash—Methotrexate—esophageal cancer	0.000621	0.00302	CcSEcCtD
Ethosuximide—Dermatitis—Methotrexate—esophageal cancer	0.000621	0.00301	CcSEcCtD
Ethosuximide—Headache—Methotrexate—esophageal cancer	0.000617	0.003	CcSEcCtD
Ethosuximide—CYP3A7—Metabolism—BLVRB—esophageal cancer	0.000615	0.000775	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—SLC52A3—esophageal cancer	0.000615	0.000775	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PTGS1—esophageal cancer	0.000608	0.000766	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—ENO1—esophageal cancer	0.000608	0.000766	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PSME1—esophageal cancer	0.000599	0.000754	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PSME2—esophageal cancer	0.000599	0.000754	CbGpPWpGaD
Ethosuximide—Nausea—Methotrexate—esophageal cancer	0.000585	0.00284	CcSEcCtD
Ethosuximide—CACNA1G—Developmental Biology—EP300—esophageal cancer	0.000546	0.000688	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.00054	0.00068	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CA1—esophageal cancer	0.000523	0.000659	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—SLC10A2—esophageal cancer	0.000523	0.000659	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CYP1B1—esophageal cancer	0.000517	0.000651	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.000513	0.000647	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000507	0.000639	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CYP19A1—esophageal cancer	0.000486	0.000612	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000481	0.000606	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CA2—esophageal cancer	0.000478	0.000602	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—EGFR—esophageal cancer	0.000466	0.000587	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—BLVRB—esophageal cancer	0.000445	0.000561	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—SLC52A3—esophageal cancer	0.000445	0.000561	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PLCE1—esophageal cancer	0.000445	0.00056	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ADH7—esophageal cancer	0.000445	0.00056	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—BLVRB—esophageal cancer	0.000445	0.00056	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—SLC52A3—esophageal cancer	0.000445	0.00056	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—HMOX1—esophageal cancer	0.000443	0.000559	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—ABCB1—esophageal cancer	0.000426	0.000536	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.000409	0.000515	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000403	0.000508	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ADH1B—esophageal cancer	0.00039	0.000491	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000385	0.000484	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000379	0.000478	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CA1—esophageal cancer	0.000379	0.000477	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—SLC10A2—esophageal cancer	0.000379	0.000477	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CA1—esophageal cancer	0.000378	0.000476	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—SLC10A2—esophageal cancer	0.000378	0.000476	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—TYMP—esophageal cancer	0.000373	0.000469	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CYP26A1—esophageal cancer	0.000362	0.000457	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ALOX15—esophageal cancer	0.000353	0.000445	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CA2—esophageal cancer	0.000346	0.000436	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CA2—esophageal cancer	0.000346	0.000435	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GSTO1—esophageal cancer	0.000337	0.000424	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—TPI1—esophageal cancer	0.000337	0.000424	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ALDOB—esophageal cancer	0.000323	0.000407	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PLCE1—esophageal cancer	0.000322	0.000406	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ADH7—esophageal cancer	0.000322	0.000406	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PLCE1—esophageal cancer	0.000321	0.000405	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ADH7—esophageal cancer	0.000321	0.000405	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GAPDH—esophageal cancer	0.000311	0.000392	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CRABP1—esophageal cancer	0.000308	0.000388	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GNG7—esophageal cancer	0.000293	0.000369	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CREBBP—esophageal cancer	0.000284	0.000358	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ADH1B—esophageal cancer	0.000282	0.000356	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ADH1B—esophageal cancer	0.000282	0.000355	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ALDH2—esophageal cancer	0.000275	0.000346	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—TYMP—esophageal cancer	0.00027	0.00034	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—TYMP—esophageal cancer	0.000269	0.000339	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CYP26A1—esophageal cancer	0.000263	0.000331	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CYP26A1—esophageal cancer	0.000262	0.00033	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GSTT1—esophageal cancer	0.000261	0.000329	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CYP2A6—esophageal cancer	0.000258	0.000325	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ALOX15—esophageal cancer	0.000256	0.000322	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ALOX15—esophageal cancer	0.000255	0.000322	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—NOS3—esophageal cancer	0.000255	0.000321	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PTGS1—esophageal cancer	0.000245	0.000308	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ENO1—esophageal cancer	0.000245	0.000308	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GSTO1—esophageal cancer	0.000244	0.000307	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—TPI1—esophageal cancer	0.000244	0.000307	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GSTO1—esophageal cancer	0.000244	0.000307	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—TPI1—esophageal cancer	0.000244	0.000307	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PSME2—esophageal cancer	0.000241	0.000304	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PSME1—esophageal cancer	0.000241	0.000304	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ALDOB—esophageal cancer	0.000234	0.000295	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ALDOB—esophageal cancer	0.000234	0.000294	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PTGS2—esophageal cancer	0.000233	0.000293	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GAPDH—esophageal cancer	0.000225	0.000284	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GAPDH—esophageal cancer	0.000225	0.000283	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CRABP1—esophageal cancer	0.000223	0.000281	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CRABP1—esophageal cancer	0.000223	0.000281	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GNG7—esophageal cancer	0.000212	0.000267	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GNG7—esophageal cancer	0.000212	0.000267	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CYP1B1—esophageal cancer	0.000208	0.000262	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.000207	0.00026	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.000207	0.00026	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ALDH2—esophageal cancer	0.000199	0.000251	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ALDH2—esophageal cancer	0.000199	0.00025	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CYP19A1—esophageal cancer	0.000196	0.000247	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—EP300—esophageal cancer	0.000194	0.000244	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GSTT1—esophageal cancer	0.000189	0.000238	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GSTT1—esophageal cancer	0.000189	0.000238	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CYP2A6—esophageal cancer	0.000187	0.000236	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CYP2A6—esophageal cancer	0.000187	0.000235	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—HMOX1—esophageal cancer	0.000179	0.000225	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ENO1—esophageal cancer	0.000177	0.000223	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PTGS1—esophageal cancer	0.000177	0.000223	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ENO1—esophageal cancer	0.000177	0.000223	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PTGS1—esophageal cancer	0.000177	0.000223	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CA1—esophageal cancer	0.000176	0.000221	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—SLC10A2—esophageal cancer	0.000176	0.000221	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PSME1—esophageal cancer	0.000175	0.00022	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PSME2—esophageal cancer	0.000175	0.00022	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PSME2—esophageal cancer	0.000174	0.00022	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PSME1—esophageal cancer	0.000174	0.00022	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ABCB1—esophageal cancer	0.000171	0.000216	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CA2—esophageal cancer	0.000161	0.000202	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CYP1B1—esophageal cancer	0.000151	0.00019	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CYP1B1—esophageal cancer	0.00015	0.00019	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PLCE1—esophageal cancer	0.000149	0.000188	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ADH7—esophageal cancer	0.000149	0.000188	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PIK3CA—esophageal cancer	0.000143	0.000181	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CYP19A1—esophageal cancer	0.000142	0.000179	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CYP19A1—esophageal cancer	0.000141	0.000178	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ADH1B—esophageal cancer	0.000131	0.000165	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—HMOX1—esophageal cancer	0.000129	0.000163	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—HMOX1—esophageal cancer	0.000129	0.000163	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—TYMP—esophageal cancer	0.000125	0.000158	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ABCB1—esophageal cancer	0.000124	0.000156	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ABCB1—esophageal cancer	0.000124	0.000156	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CYP26A1—esophageal cancer	0.000122	0.000153	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ALOX15—esophageal cancer	0.000119	0.00015	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CREBBP—esophageal cancer	0.000115	0.000144	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—TPI1—esophageal cancer	0.000113	0.000143	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GSTO1—esophageal cancer	0.000113	0.000143	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ALDOB—esophageal cancer	0.000109	0.000137	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GAPDH—esophageal cancer	0.000105	0.000132	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CRABP1—esophageal cancer	0.000104	0.00013	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—NOS3—esophageal cancer	0.000103	0.000129	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GNG7—esophageal cancer	9.85e-05	0.000124	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PTGS2—esophageal cancer	9.38e-05	0.000118	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ALDH2—esophageal cancer	9.23e-05	0.000116	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GSTT1—esophageal cancer	8.78e-05	0.000111	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CYP2A6—esophageal cancer	8.68e-05	0.000109	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CREBBP—esophageal cancer	8.3e-05	0.000105	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CREBBP—esophageal cancer	8.28e-05	0.000104	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ENO1—esophageal cancer	8.23e-05	0.000104	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PTGS1—esophageal cancer	8.23e-05	0.000104	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PSME1—esophageal cancer	8.11e-05	0.000102	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PSME2—esophageal cancer	8.11e-05	0.000102	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—EP300—esophageal cancer	7.8e-05	9.83e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—NOS3—esophageal cancer	7.43e-05	9.36e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—NOS3—esophageal cancer	7.41e-05	9.34e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CYP1B1—esophageal cancer	7e-05	8.81e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PTGS2—esophageal cancer	6.8e-05	8.56e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PTGS2—esophageal cancer	6.78e-05	8.54e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CYP19A1—esophageal cancer	6.58e-05	8.28e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—HMOX1—esophageal cancer	6e-05	7.56e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PIK3CA—esophageal cancer	5.77e-05	7.27e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ABCB1—esophageal cancer	5.76e-05	7.26e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—EP300—esophageal cancer	5.65e-05	7.12e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—EP300—esophageal cancer	5.64e-05	7.1e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PIK3CA—esophageal cancer	4.18e-05	5.27e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PIK3CA—esophageal cancer	4.17e-05	5.26e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CREBBP—esophageal cancer	3.85e-05	4.85e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—NOS3—esophageal cancer	3.45e-05	4.34e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PTGS2—esophageal cancer	3.15e-05	3.97e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—EP300—esophageal cancer	2.62e-05	3.3e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.94e-05	2.44e-05	CbGpPWpGaD
